A comprehensive document on platform trials is now available

The domain of EU-PEARL’s research, Integrated Research Platforms (IRPs) and platform trials is relatively new...
Read More

“Beyond COVID-19, our collective effort will ensure that many more patients benefit from platform trials”

As the biomedical sector rapidly mobilizes to address the novel coronavirus pandemic, we are encouraged...
Read More

EU-PEARL plan to foster patient engagement in the design of the platform trial framework takes off

Patient centricity is at the core of EU-PEARL’s mission. That is why we are engaging...
Read More

Get to know Juan M Pericàs, member of EU-PEARL scientific coordination team

Physician, specialised in internal medicine, infectious diseases and epidemiology/public health. EU-PEARL’s scientific co-coordinator, giving support...
Read More

EU-PEARL to present the potential of the platform trials framework in CTFs Annual Conference

EU-PEARL will participate in the Children’s Tumor Foundation (CTF) Annual Conference which will take place...
Read More

Have you ever participated in a clinical trial as a patient? If so, we would like to hear from you

On 29 May, EU PEARL launched a call for testimonials to collect feedback on patient’s...
Read More

Read the press release announcing the launch of EU-PEARL

The EU-PEARL project aims to shape future drug development through a systematic approach that enables...
Read More

EU-PEARL kicked off with a team meeting in Barcelona. Curious to learn how it went?

EU-PEARL kick-off meeting took place in November 21st and 22nd, 2019. Barcelona welcomed over 120...
Read More

IMI will fund EU-PEARL project set to develop a new paradigm for clinical trials

The Innovative Medicines Initiative has approved a 26 million euros project to advance in the...
Read More

Sign up to stay informed

Subscribe here to our newsletter and stay updated on the latest developments: